This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3fdn
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | |||
==Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and specificity== | ==Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and specificity== | ||
<StructureSection load='3fdn' size='340' side='right' caption='[[3fdn]], [[Resolution|resolution]] 1.90Å' scene=''> | <StructureSection load='3fdn' size='340' side='right' caption='[[3fdn]], [[Resolution|resolution]] 1.90Å' scene=''> | ||
| Line 5: | Line 6: | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MMH:N-[3-(ACETYLAMINO)PHENYL]-5-{(2E)-2-[(4-METHOXYPHENYL)METHYLIDENE]HYDRAZINO}-3-METHYL-1H-PYRAZOLE-4-CARBOXAMIDE'>MMH</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MMH:N-[3-(ACETYLAMINO)PHENYL]-5-{(2E)-2-[(4-METHOXYPHENYL)METHYLIDENE]HYDRAZINO}-3-METHYL-1H-PYRAZOLE-4-CARBOXAMIDE'>MMH</scene></td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] </span></td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3fdn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3fdn OCA], [http://pdbe.org/3fdn PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3fdn RCSB], [http://www.ebi.ac.uk/pdbsum/3fdn PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3fdn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3fdn OCA], [http://pdbe.org/3fdn PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3fdn RCSB], [http://www.ebi.ac.uk/pdbsum/3fdn PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3fdn ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
| Line 13: | Line 14: | ||
Check<jmol> | Check<jmol> | ||
<jmolCheckbox> | <jmolCheckbox> | ||
| - | <scriptWhenChecked>select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/fd/3fdn_consurf.spt"</scriptWhenChecked> | + | <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/fd/3fdn_consurf.spt"</scriptWhenChecked> |
<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked> | <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked> | ||
<text>to colour the structure by Evolutionary Conservation</text> | <text>to colour the structure by Evolutionary Conservation</text> | ||
| Line 50: | Line 51: | ||
[[Category: Nucleotide-binding]] | [[Category: Nucleotide-binding]] | ||
[[Category: Phosphoprotein]] | [[Category: Phosphoprotein]] | ||
| + | [[Category: Polymorphism]] | ||
[[Category: Serine/threonine-protein kinase]] | [[Category: Serine/threonine-protein kinase]] | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
[[Category: Virtual screening]] | [[Category: Virtual screening]] | ||
[[Category: X-ray co-crystal analysis]] | [[Category: X-ray co-crystal analysis]] | ||
Revision as of 07:34, 5 December 2018
Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and specificity
| |||||||||||
Categories: Human | Non-specific serine/threonine protein kinase | Coumar, M S | Hsieh, H P | Leou, J S | Shukla, P | Wu, J S | Wu, S Y | Atp-binding | Aurora kinase inhibitor | Cell cycle | H-bonding | Kinase | Nucleotide-binding | Phosphoprotein | Polymorphism | Serine/threonine-protein kinase | Transferase | Virtual screening | X-ray co-crystal analysis
